FDA Approved: SODIUM OXYBATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for sodium oxybate filed by Hikma Pharmaceuticals USA Inc. for its narcolepsy treatment product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• Sodium Oxybate (Xyrem) (Sodium Oxybate)

Snippet

SUPPL AP for SODIUM OXYBATE (SODIUM OXYBATE)